Antonis A. Armoundas

Clinical AI and Precision Medicine: Philosophical Questions About Labels, Disease, and Evidence

Precision medicine is often framed as a move from “average-patient” care toward prevention, diagnosis, and treatment tailored to individual variability. This aspiration has been articulated in major policy and scientific calls for a new evidence-generating health system and a new...

Artificial intelligence in clinical trials—state of the evidence, gaps, and next steps

Artificial intelligence (AI) affects clinical trials in two distinct but overlapping ways: as the intervention under evaluation and as infrastructure supporting trial design, recruitment, monitoring, endpoint assessment, analysis, and reporting. In this manuscript, we define AI-a...